| Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis M Federico, MDC Barrigón, L Marcheselli, V Tarantino, M Manni, ... The Lancet Haematology 5 (8), e359-e367, 2018 | 108 | 2018 |
| Validation of the NCCN‐IPI for diffuse large B‐cell lymphoma (DLBCL): the addition of β2‐microglobulin yields a more accurate GELTAMO‐IPI C Montalbán, A Díaz‐López, I Dlouhy, J Rovira, A Lopez‐Guillermo, ... British Journal of Haematology 176 (6), 918-928, 2017 | 100 | 2017 |
| Plitidepsin: design, development, and potential place in therapy S Alonso-Álvarez, E Pardal, D Sánchez-Nieto, M Navarro, MD Caballero, ... Drug Design, Development and Therapy, 253-264, 2017 | 92 | 2017 |
| Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group S Alonso‐Álvarez, L Magnano, M Alcoceba, M Andrade‐Campos, ... British journal of haematology 178 (5), 699-708, 2017 | 77 | 2017 |
| From Waldenström’s macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation C Jiménez, S Alonso-Álvarez, M Alcoceba, GR Ordóñez, ... Blood cancer journal 7 (8), e591-e591, 2017 | 39 | 2017 |
| Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population L Magnano, S Alonso‐Alvarez, M Alcoceba, A Rivas‐Delgado, ... British Journal of Haematology 185 (3), 480-491, 2019 | 37 | 2019 |
| The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy S Alonso-Álvarez, MB Vidriales, MD Caballero, O Blanco, N Puig, ... Leukemia & lymphoma 58 (5), 1144-1152, 2017 | 36 | 2017 |
| Evaluation of the regimen brentuximab vedotin plus ESHAP (BRESHAP) in refractory or relapsed Hodgkin lymphoma patients: preliminary results of a phase I-II trial from the … R Garcia-Sanz, A Sureda, S Alonso-Alvarez, AP Gonzalez, A Rodriguez, ... Blood 126 (23), 582, 2015 | 28 | 2015 |
| Refractoriness to immunochemotherapy in follicular lymphoma: predictive factors and outcome M Sorigue, S Mercadal, S Alonso, R Fernández‐Álvarez, O García, ... Hematological Oncology 35 (4), 520-527, 2017 | 25 | 2017 |
| The impact of antimicrobial prophylaxis in morbidity and infections during azacitidine treatment N Lorenzana, LF Avila, S Alonso, E Colado, T Bernal Annals of hematology 96, 1833-1840, 2017 | 20 | 2017 |
| Ischemic stroke outcome and early infection: its deleterious effect seems to operate also among tissue plasminogen activator-treated patients D Salat, P Delgado, S Alonso, M Ribó, E Santamarina, M Quintana, ... European Neurology 65 (2), 82-87, 2011 | 16 | 2011 |
| Expression of CD47 antigen in Reed–Sternberg cells as a new potential biomarker for classical Hodgkin lymphoma B López-Pereira, AA Fernández-Velasco, I Fernández-Vega, ... Clinical and Translational Oncology 22, 782-785, 2020 | 14 | 2020 |
| Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas M García-Álvarez, S Alonso-Álvarez, I Prieto-Conde, C Jiménez, ... Blood Cancer Journal 9 (7), 52, 2019 | 14 | 2019 |
| Evidence of long-term disease control with panobinostat maintenance in patients with relapsed multiple myeloma EM Ocio, J Dávila, JC Caballero, S Alonso, VG de la Calle, R García-Sanz, ... haematologica 100 (7), e289, 2015 | 11 | 2015 |
| Acute graft-versus-host disease and bronchiolitis obliterans after autologous stem cell transplantation in a patient with multiple myeloma S Alonso, M Cabrero, JC Caballero, J Dávila, VG de la Calle, ... Clinical Case Reports 3 (6), 370, 2015 | 8 | 2015 |
| Lymphoma heterogeneity: three different histological pictures and one unique clone S Alonso-Alvarez, A Redondo-Guijo, Ó Blanco, M Alcoceba, ... Case Reports in Hematology 2016 (1), 3947510, 2016 | 7 | 2016 |
| Late differentiation syndrome in acute promyelocytic leukemia: a challenging diagnosis R Cabral, JC Caballero, S Alonso, J Dávila, M Cabrero, D Caballero, ... Hematology reports 6 (4), 5654, 2014 | 7 | 2014 |
| Genomic analysis of a familial myelodysplasia/acute myeloid leukemia and inherited RUNX1 mutations without a pre-existing platelet disorder MI Prieto-Conde, J Labrador, G Hermida, S Alonso, C Jiménez, ... Leukemia & Lymphoma 61 (1), 181-184, 2020 | 4 | 2020 |
| Unmet needs in histological transformation of follicular lymphoma: a clinical and biological review M Alcoceba, S Alonso-Álvarez, M García-Álvarez, A Martín, MD Caballero Annals of Lymphoma 1 (5), 2017 | 4 | 2017 |
| Is there a role for the international prognostic index in follicular lymphoma? M Sorigue, S Mercadal, S Alonso, R Fernández-Álvarez, JM Sancho Annals of Hematology 97, 713-715, 2018 | 3 | 2018 |
